Royal Bank Of Canada Analysts Give athenahealth, Inc. (ATHN) a $144.00 Price Target

athenahealth, Inc. (NASDAQ:ATHN) has been given a $144.00 price target by Royal Bank Of Canada in a research note issued on Friday. The brokerage currently has a “hold” rating on the health services provider’s stock. Royal Bank Of Canada’s price target would suggest a potential upside of 14.25% from the company’s previous close.

A number of other research analysts have also weighed in on the stock. ValuEngine raised shares of athenahealth from a “sell” rating to a “hold” rating in a research note on Monday, July 24th. Evercore ISI reissued an “outperform” rating and issued a $163.00 target price (up from $155.00) on shares of athenahealth in a research note on Saturday, July 22nd. Cowen and Company lowered shares of athenahealth from an “outperform” rating to a “market perform” rating and raised their target price for the stock from $127.00 to $133.00 in a research note on Monday, July 31st. Jefferies Group LLC reissued a “hold” rating and issued a $135.00 target price on shares of athenahealth in a research note on Monday, June 26th. Finally, Oppenheimer Holdings, Inc. reissued a “buy” rating and issued a $184.00 target price on shares of athenahealth in a research note on Friday. Three equities research analysts have rated the stock with a sell rating, thirteen have assigned a hold rating and eleven have issued a buy rating to the stock. athenahealth presently has an average rating of “Hold” and an average price target of $147.83.

Shares of athenahealth (NASDAQ ATHN) opened at 126.04 on Friday. The stock has a 50 day moving average price of $125.37 and a 200 day moving average price of $130.33. athenahealth has a one year low of $90.11 and a one year high of $158.66. The company has a market capitalization of $5.03 billion, a PE ratio of 159.95 and a beta of 1.76.

athenahealth (NASDAQ:ATHN) last issued its quarterly earnings results on Thursday, October 19th. The health services provider reported $0.56 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.50 by $0.06. The firm had revenue of $304.60 million for the quarter, compared to analyst estimates of $310.52 million. athenahealth had a net margin of 2.65% and a return on equity of 6.94%. athenahealth’s quarterly revenue was up 10.1% compared to the same quarter last year. During the same period last year, the company posted $0.60 EPS. On average, equities research analysts predict that athenahealth will post $1.91 earnings per share for the current year.

TRADEMARK VIOLATION WARNING: “Royal Bank Of Canada Analysts Give athenahealth, Inc. (ATHN) a $144.00 Price Target” was reported by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are viewing this article on another publication, it was illegally stolen and reposted in violation of US and international copyright and trademark law. The legal version of this article can be read at https://ledgergazette.com/2017/10/21/royal-bank-of-canada-analysts-give-athenahealth-inc-athn-a-144-00-price-target.html.

In related news, Director Brandon H. Hull sold 800 shares of athenahealth stock in a transaction that occurred on Tuesday, August 1st. The shares were sold at an average price of $140.01, for a total value of $112,008.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Jonathan Bush sold 4,000 shares of athenahealth stock in a transaction that occurred on Monday, October 2nd. The shares were sold at an average price of $124.17, for a total transaction of $496,680.00. Following the completion of the sale, the chief executive officer now owns 319,807 shares of the company’s stock, valued at approximately $39,710,435.19. The disclosure for this sale can be found here. Insiders sold a total of 15,783 shares of company stock valued at $2,132,924 in the last quarter. 3.20% of the stock is owned by insiders.

Hedge funds have recently modified their holdings of the business. Elliott Management Corp purchased a new position in athenahealth in the 2nd quarter valued at approximately $52,706,000. UBS Asset Management Americas Inc. boosted its position in athenahealth by 33.2% in the 2nd quarter. UBS Asset Management Americas Inc. now owns 30,536 shares of the health services provider’s stock valued at $4,292,000 after buying an additional 7,605 shares during the period. Scout Investments Inc. boosted its position in athenahealth by 67.2% in the 2nd quarter. Scout Investments Inc. now owns 115,663 shares of the health services provider’s stock valued at $16,256,000 after buying an additional 46,507 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank boosted its position in athenahealth by 1.7% in the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank

A number of other research analysts have also weighed in on the stock. ValuEngine raised shares of athenahealth from a “sell” rating to a “hold” rating in a research note on Monday, July 24th. Evercore ISI reissued an “outperform” rating and issued a $163.00 target price (up from $155.00) on shares of athenahealth in a research note on Saturday, July 22nd. Cowen and Company lowered shares of athenahealth from an “outperform” rating to a “market perform” rating and raised their target price for the stock from $127.00 to $133.00 in a research note on Monday, July 31st. Jefferies Group LLC reissued a “hold” rating and issued a $135.00 target price on shares of athenahealth in a research note on Monday, June 26th. Finally, Oppenheimer Holdings, Inc. reissued a “buy” rating and issued a $184.00 target price on shares of athenahealth in a research note on Friday. Three equities research analysts have rated the stock with a sell rating, thirteen have assigned a hold rating and eleven have issued a buy rating to the stock. athenahealth presently has an average rating of “Hold” and an average price target of $147.83.

Shares of athenahealth (NASDAQ ATHN) opened at 126.04 on Friday. The stock has a 50 day moving average price of $125.37 and a 200 day moving average price of $130.33. athenahealth has a one year low of $90.11 and a one year high of $158.66. The company has a market capitalization of $5.03 billion, a PE ratio of 159.95 and a beta of 1.76.

athenahealth (NASDAQ:ATHN) last issued its quarterly earnings results on Thursday, October 19th. The health services provider reported $0.56 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.50 by $0.06. The firm had revenue of $304.60 million for the quarter, compared to analyst estimates of $310.52 million. athenahealth had a net margin of 2.65% and a return on equity of 6.94%. athenahealth’s quarterly revenue was up 10.1% compared to the same quarter last year. During the same period last year, the company posted $0.60 EPS. On average, equities research analysts predict that athenahealth will post $1.91 earnings per share for the current year.

TRADEMARK VIOLATION WARNING: “Royal Bank Of Canada Analysts Give athenahealth, Inc. (ATHN) a $144.00 Price Target” was reported by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are viewing this article on another publication, it was illegally stolen and reposted in violation of US and international copyright and trademark law. The legal version of this article can be read at https://ledgergazette.com/2017/10/21/royal-bank-of-canada-analysts-give-athenahealth-inc-athn-a-144-00-price-target.html.

In related news, Director Brandon H. Hull sold 800 shares of athenahealth stock in a transaction that occurred on Tuesday, August 1st. The shares were sold at an average price of $140.01, for a total value of $112,008.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Jonathan Bush sold 4,000 shares of athenahealth stock in a transaction that occurred on Monday, October 2nd. The shares were sold at an average price of $124.17, for a total transaction of $496,680.00. Following the completion of the sale, the chief executive officer now owns 319,807 shares of the company’s stock, valued at approximately $39,710,435.19. The disclosure for this sale can be found here. Insiders sold a total of 15,783 shares of company stock valued at $2,132,924 in the last quarter. 3.20% of the stock is owned by insiders.

Hedge funds have recently modified their holdings of the business. Elliott Management Corp purchased a new position in athenahealth in the 2nd quarter valued at approximately $52,706,000. UBS Asset Management Americas Inc. boosted its position in athenahealth by 33.2% in the 2nd quarter. UBS Asset Management Americas Inc. now owns 30,536 shares of the health services provider’s stock valued at $4,292,000 after buying an additional 7,605 shares during the period. Scout Investments Inc. boosted its position in athenahealth by 67.2% in the 2nd quarter. Scout Investments Inc. now owns 115,663 shares of the health services provider’s stock valued at $16,256,000 after buying an additional 46,507 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank boosted its position in athenahealth by 1.7% in the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 72,918 shares of the health services provider’s stock valued at $10,249,000 after buying an additional 1,222 shares during the period. Finally, Schwab Charles Investment Management Inc. boosted its position in athenahealth by 6.2% in the 2nd quarter. Schwab Charles Investment Management Inc. now owns 170,978 shares of the health services provider’s stock valued at $24,031,000 after buying an additional 9,960 shares during the period.

athenahealth Company Profile

athenahealth, Inc provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet.

Analyst Recommendations for athenahealth (NASDAQ:ATHN)

Receive News & Ratings for athenahealth Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply